MacroGenics | MGNX - Stammkapital

Aktienkurs
3.19
Täglich Wechseln
0.01 0.31%
Monatlich
0.63%
Jährlich
86.55%
Q2 Prognose
3.12




Stammkapital Veränderung Datum
AbbVie USD 1.77B 1.75B 2025-06
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Daiichi Sankyo JPY 1.85B 9K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Genmab DKK 61.62M 52K 2025-12
Geron USD 638.36M 338K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
J&J USD 2.41B 1.74M 2025-12
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
MacroGenics USD 63.32M 60K 2025-12
Merck USD 2.49B 15.79M 2025-09
Pfizer USD 5.69B 1000K 2025-09
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Xencor USD 71.87M 529K 2025-12